PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

Biotech Time?, page-12

  1. 762 Posts.
    lightbulb Created with Sketch. 140
    I'm not sure if I agree with your interpretation, Denial re. 002, stage 1.

    PAR's statement that you quote is vague and no specific conclusions can be made from it.

    The market is currently intepretating the half yearly as poor.


    Last edited by MixedBag: 28/02/24
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.